[go: up one dir, main page]

DK0824696T3 - Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor - Google Patents

Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor

Info

Publication number
DK0824696T3
DK0824696T3 DK96919762T DK96919762T DK0824696T3 DK 0824696 T3 DK0824696 T3 DK 0824696T3 DK 96919762 T DK96919762 T DK 96919762T DK 96919762 T DK96919762 T DK 96919762T DK 0824696 T3 DK0824696 T3 DK 0824696T3
Authority
DK
Denmark
Prior art keywords
tumour
cells
drug
therapeutic response
sample
Prior art date
Application number
DK96919762T
Other languages
Danish (da)
English (en)
Inventor
Leif Hakansson
Annika Hakansson
Bertil Gustafsson
Original Assignee
Landstinget I Oestergoetland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Landstinget I Oestergoetland filed Critical Landstinget I Oestergoetland
Application granted granted Critical
Publication of DK0824696T3 publication Critical patent/DK0824696T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK96919762T 1995-05-12 1996-05-10 Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor DK0824696T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501782A SE9501782D0 (sv) 1995-05-12 1995-05-12 Method of predicting the therapeutic response of a drug against a malignant tumour
PCT/EP1996/002007 WO1996035949A1 (fr) 1995-05-12 1996-05-10 Procede et kit permettant de predire la reponse therapeutique d'un medicament contre une tumeur maligne

Publications (1)

Publication Number Publication Date
DK0824696T3 true DK0824696T3 (da) 2001-01-02

Family

ID=20398299

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96919762T DK0824696T3 (da) 1995-05-12 1996-05-10 Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor

Country Status (12)

Country Link
US (1) US6114128A (fr)
EP (1) EP0824696B1 (fr)
JP (1) JPH11504715A (fr)
AT (1) ATE196688T1 (fr)
CA (1) CA2215627A1 (fr)
DE (1) DE69610496T2 (fr)
DK (1) DK0824696T3 (fr)
ES (1) ES2151665T3 (fr)
GR (1) GR3034891T3 (fr)
PT (1) PT824696E (fr)
SE (1) SE9501782D0 (fr)
WO (1) WO1996035949A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824467A (en) * 1997-02-25 1998-10-20 Celtrix Pharmaceuticals Methods for predicting drug response
US6087090A (en) * 1997-02-25 2000-07-11 Celtrix Pharmaceuticals, Inc. Methods for predicting drug response
US20030096237A1 (en) * 2000-08-28 2003-05-22 Ulrich Certa Determination of the ability of patients to respond to a tumor treatment
SE0402536D0 (sv) 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
CN102695512B (zh) 2009-10-19 2017-05-10 罗斯塔库奥股份公司 用于药物基因组学治疗心血管病症的方法和系统
WO2012024236A1 (fr) * 2010-08-14 2012-02-23 Biogen Idec Ma Inc. Blocage des ltβr : procédés pour optimiser la sensibilité thérapeutique de patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
CA1296622C (fr) * 1986-08-12 1992-03-03 Jeffrey E. Anderson Methode et appareil d'evaluation automatisee de l'immuno-regulationdu systeme immunitaire des mononucleaires

Also Published As

Publication number Publication date
US6114128A (en) 2000-09-05
EP0824696B1 (fr) 2000-09-27
CA2215627A1 (fr) 1996-11-14
DE69610496T2 (de) 2001-05-10
EP0824696A1 (fr) 1998-02-25
PT824696E (pt) 2001-03-30
JPH11504715A (ja) 1999-04-27
ES2151665T3 (es) 2001-01-01
WO1996035949A1 (fr) 1996-11-14
SE9501782D0 (sv) 1995-05-12
ATE196688T1 (de) 2000-10-15
DE69610496D1 (de) 2000-11-02
GR3034891T3 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
Kolk et al. Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae
Edwards Immunologic investigations of meningococcal disease: I. Group-specific Neisseria meningitidis antigens present in the serum of patients with fulminant meningococcemia
Shin et al. Monocytoid B-cell lymphoma in patients with Sjögren's syndrome: a clinicopathologic study of 13 patients
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
ATE318147T1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
EP0852004A2 (fr) Analyse multiplexee de specimens cliniques
NZ518363A (en) Elisa for vascular endothelial growth factor using monoclonal and polyclonal antibodies
DK0559795T3 (da) Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen
WO2005034008A3 (fr) Procede d'essai anonyme et fourniture de resultats d'essai a un patient
EP1102988B8 (fr) Procede d'evaluation de l'activite de la reponse immunitaire du sang et trousse d'essai correspondante
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
Bloom et al. In vitro methods in cell-mediated immunity: a progress report
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
EP0352722A3 (fr) Procédés de liaison d'antigène d'adènocarcinome et réactifs
SE8701905L (sv) Foerfarande och kit foer diagnos av iga-nefropati
DK0824696T3 (da) Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
Emmitt et al. Crossed immunoelectrophoresis: qualitative and quantitative considerations
Armitage et al. Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation
PL322209A1 (en) Detection of antibody production
NO168311C (no) Monoklonale antistoffer for humane ikke-smaacelle lungekarsinomer, cellelinjer som produserer disse samt diagnostisksett
ATE130100T1 (de) Verfahren zur immunologischen erkennung maligner tumore und kit zur durchführung dieses verfahrens.
DE69619667D1 (de) Überwachung der immunotherapie von malignen tumoren
ATE228249T1 (de) Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm
KR970702928A (ko) 크립토콕쿠스증에 대해 위험이 큰 면역약화된 환자의 동정 방법(Method to identify immunocompromised patients at high risk for cryptococcosis)